These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 33799105)

  • 1. Interrelationships between heath utility measurements, disease activity and psychological factors in Behçet's disease.
    Murray PI; Sekaran A; Javidi H; Situnayake D
    Gen Hosp Psychiatry; 2021; 70():103-108. PubMed ID: 33799105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of depression, anxiety and fatigue in patients with Behçet's disease.
    Can Sandikci S; Colak S; Omma A; Enecik ME
    Int J Rheum Dis; 2019 Jun; 22(6):974-979. PubMed ID: 30398004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore population.
    Au Eong KG; Chan EW; Luo N; Wong SH; Tan NW; Lim TH; Wagle AM
    Eye (Lond); 2012 Mar; 26(3):379-88. PubMed ID: 22222257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creating a Health Utility Value for Birdshot Chorioretinopathy.
    Sekaran A; Shamdas M; Barry RJ; Denniston AK; Murray PI
    Ocul Immunol Inflamm; 2022 Jan; 30(1):73-80. PubMed ID: 32946293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health state utilities and subjective well-being among psoriasis vulgaris patients in mainland China.
    Liu L; Li S; Zhao Y; Zhang J; Chen G
    Qual Life Res; 2018 May; 27(5):1323-1333. PubMed ID: 29492743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of medical, demographic and psychosocial factors to direct and indirect health utility instruments in rheumatoid arthritis.
    Witney AG; Treharne GJ; Tavakoli M; Lyons AC; Vincent K; Scott DL; Kitas GD
    Rheumatology (Oxford); 2006 Aug; 45(8):975-81. PubMed ID: 16461437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility, comparability, and reliability of the standard gamble compared with the rating scale and time trade-off techniques in Korean population.
    Kim SH; Lee SI; Jo MW
    Qual Life Res; 2017 Dec; 26(12):3387-3397. PubMed ID: 28801862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue in patients with Behçet's syndrome: relationship with quality of life, depression, anxiety, disability and disease activity.
    Ilhan B; Can M; Alibaz-Oner F; Yilmaz-Oner S; Polat-Korkmaz O; Ozen G; Mumcu G; Maradit Kremers H; Direskeneli H
    Int J Rheum Dis; 2018 Dec; 21(12):2139-2145. PubMed ID: 26913703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L.
    Hobbins A; Barry L; Kelleher D; Shah K; Devlin N; Goni JMR; O'Neill C
    Pharmacoeconomics; 2018 Nov; 36(11):1345-1353. PubMed ID: 30051267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting and valuing one's own health: a think aloud study using EQ-5D-5L, EQ VAS and a time trade-off question among patients with a chronic condition.
    Ernstsson O; Burström K; Heintz E; Mølsted Alvesson H
    Health Qual Life Outcomes; 2020 Dec; 18(1):388. PubMed ID: 33334348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.
    Wei QQ; Hou Y; Chen Y; Ou R; Cao B; Zhang L; Yang T; Shang H
    Health Qual Life Outcomes; 2021 Jul; 19(1):181. PubMed ID: 34284776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in patients with uveitis.
    Shamdas M; Bassilious K; Murray PI
    Br J Ophthalmol; 2019 Sep; 103(9):1284-1288. PubMed ID: 30361275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
    Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
    Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The construct validity and responsiveness of the EQ-5D-5L, AQL-5D and a bespoke TTO in acute asthmatics.
    Crossman-Barnes CJ; Sach T; Wilson A; Barton G
    Qual Life Res; 2020 Mar; 29(3):619-627. PubMed ID: 31676971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis.
    Liem YS; Bosch JL; Hunink MG
    Value Health; 2008; 11(4):733-41. PubMed ID: 18194399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study.
    Sayah FA; Bansback N; Bryan S; Ohinmaa A; Poissant L; Pullenayegum E; Xie F; Johnson JA
    Qual Life Res; 2016 Jul; 25(7):1679-85. PubMed ID: 26659899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV disease.
    Joyce VR; Barnett PG; Bayoumi AM; Griffin SC; Kyriakides TC; Yu W; Sundaram V; Holodniy M; Brown ST; Cameron W; Youle M; Sculpher M; Anis AH; Owens DK
    J Acquir Immune Defic Syndr; 2009 Jan; 50(1):27-36. PubMed ID: 19295332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
    Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
    Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.